• No results found

University of Groningen Endothelial cell transcriptional regulation in vascular disease Sol, Marloes

N/A
N/A
Protected

Academic year: 2021

Share "University of Groningen Endothelial cell transcriptional regulation in vascular disease Sol, Marloes"

Copied!
2
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

University of Groningen

Endothelial cell transcriptional regulation in vascular disease

Sol, Marloes

DOI:

10.33612/diss.136419916

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date: 2020

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

Sol, M. (2020). Endothelial cell transcriptional regulation in vascular disease. University of Groningen. https://doi.org/10.33612/diss.136419916

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)

Stellingen behorend bij het proefschrift

‘Endothelial cell transcriptional regulation in vascular disease’

1. Targeting glomerular endothelial H3K27me3 is needed to prevent the reduction of the glomerular endothelial glycocalyx in diabetic nephropathy. (this thesis, Ch 3)

2. Glomerular endothelial EZH2 contributes to glomerular extracellular matrix deposition and glomerulosclerosis in diabetic nephropathy. (this thesis, Ch 4)

3. An inducible glomerular endothelium EZH2 knock out in vivo model is necessary to really understand the role of endothelial EZH2 in the development of diabetic nephropathy. (this thesis, Ch 3 & 4)

4. PPARɣ-mediated transcriptional repression of HPSE is essential to restore the integrity of the glomerular endothelial glycocalyx in Focal Segmental Glomerulosclerosis. (this thesis, Ch 5) 5. Disturbed reciprocal signaling between MAPK7 and EZH2 in endothelial cells induces

Endothelial-to-Mesenchymal Transition and contributes to coronary atherosclerosis. (this thesis, Ch 6)

6. Glomerular endothelial dysfunction underlies the development of proteinuria and kidney failure in COVID-19 patients.

7. De wetenschap laat zich niet plannen. 8. Docendo discitur. (Seneca)

Marloes Sol 10 november 2020

Referenties

GERELATEERDE DOCUMENTEN

As well as in the cornea, diabetes mellitus–induced cardiac fibrosis and diabetic nephropathy, TGF-β induces the endothelial cells to undergo EndMT, leading to irreversible

The endothelium is pivotal in the regulation of multiple processes, including the exchange of oxygen and nutrients, vascular tone, vascular

In podocytes, H3K27me3 was previously shown to be decreased in DN, which associated with the extent of podocyte damage due to

phosphorylation of Mitogen-Activated Protein Kinase 7 (MAPK7) in endothelial cells, resulting in microRNA-101 (miR101) gene expression and a decrease in expression of Enhancer of

In dit proefschrift is aangetoond dat verhoogde expressie en activiteit van EZH2 een verlies van de endotheliale glycocalyx induceert door verlaging van de expressie van

Indeed, NTN4 knockdown endothelial cells cultured on human NTN4 coating no longer showed increased β-galactosidase staining compared to control cells (Figure 6E).. 4.3.5 NTN4

When VEGF-A binds to VEGFR-2, it will activate several complex downstream pathways which increase the permeability of the blood vessel, but also increase proliferation and migration

With respect to podocyte injury, no changes were found in the number of Wilms tumor-1 epositive podocytes or Figure 2 Monocyte chemotactic protein-1 inhibition reduces albuminuria